29 jun: Shipping: Australien sænker forventning til malmeksport - avis
29 jun: Topotarget/CFO: Præsenterer flere data inden telekonferencen
29-06-2012 09:02:49

Cermaq ASA : Presentation of Q2 results 2012

Relateret indhold
Relateret debat
24 jun - 
Puma declined to comment on the report. 192.168.0.1
24 jun - 
EBIT pre fair value was NOK 325 million in first quarte..

Cermaq presents the results for the 2nd quarter 2012 on Friday 20th July at hrs 08:

00 CEST at Thon Hotel Vika Atrium, Munkedamsveien 45, 0250 Oslo, Norway.

 

Please note that the quarterly report and presentation will be published at 06:30 CEST.

 

The presentation will be held in English and will be available as a web cast on the group's website. The web cast will adjourn immediately after the presentation.

About Cermaq - Cermaq is an international group of companies with activities in fish farming, production of salmonid feed and research in aquaculture. Cermaq has operations in Norway, Chile, Canada, and Scotland, the main geographic regions for salmon and trout farming, and in Vietnam. Through its business unit EWOS, Cermaq ranks as the world's second largest producer of feed for salmonids. The business unit Mainstream is one of the world's leading farming companies of salmon and trout. The group had sales of around NOK 11.6 billion in 2011. Cermaq is listed on the Oslo stock exchange with ticker code CEQ. www.cermaq.com

 

This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.


This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the

information contained therein.

Source: Cermaq ASA via Thomson Reuters ONE

HUG#1622951

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Genmab/Nordea: Arzerra-studier underbygger positiv holdning

01-08-2014 08:42:57
Genmab og partneren Glaxosmithkline offentliggjorde sent torsdag positive interimresultater med kræftmidlet Arzerra.Den foreløbige analyse, foretaget af en uafh..

Vestas/Jyske: Opjustering kan meget vel være på vej

31-07-2014 15:02:15
Jyske Bank har torsdag løftet anbefalingen af Vestas til "køb" fra tidligere "reducer", mens kursmålet fastholdes på 300 kr.Løftet kommer på baggrund af udsigte..

Fire banker påbydes at stoppe risikovægtning af særlån

31-07-2014 14:41:43
Finanstilsynet har påbudt fire IRB-banker, henholdsvis Danske Bank, Jyske Bank, Lån og Spar Bank og Nykredit Bank, at stoppe med at anvende en særlig lempelig r..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Vestas/Jyske: Opjustering kan meget vel være på vej
2
Aktier/middag: Novo holder skansen i rødt C20
3
Aktier/tendens: Faldene vil ebbe ud
4
Europa/aktier: Adidas i største fald i 15 år
5
Torsdagens aktier: Bredt fald anført af Pandora og Carlsberg

Relaterede aktiekurser

Cermaq ASA 79,50 0,0% Aktiekurs uændret
Euroinvestor i andre lande: Euroinvestor.com | Euroinvestor.se | Euroinvestor.no | Euroinvestor.fr | Forexinvestor.com| Wisselkoersen.nl | Valuta.se | Valutaveksel.no | Divisas.es | Valute.it
Copyright Euroinvestor A/S 2014  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
1. august 2014 09:45:48
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20140731.2 - EUROWEB2 - 2014-08-01 09:45:48 - 2014-08-01 09:45:48 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x